{"transactions":[{"id":737290,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":37979,"kind":"person","name":"DOW GEOFFREY S","position":1,"cik":"0001977231","reported_name":"DOW GEOFFREY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-06-15T20:50:47.000Z","date":"2026-06-12","kind":"purchase","planned":false,"acquired":true,"shares":7350,"price":1.3784,"value":10131.24,"ownership":{"direct":true},"balance_after":24131,"source":{"system":"sec-edgar","filing":"0001213900-26-068853","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390026068853/ownership.xml","form_type":"4"}},{"id":966926,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":37979,"kind":"person","name":"DOW GEOFFREY S","position":1,"cik":"0001977231","reported_name":"DOW GEOFFREY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-12-16T22:41:35.000Z","date":"2025-12-15","kind":"purchase","planned":false,"acquired":true,"shares":9670,"price":0.8024,"value":7759.208,"ownership":{"direct":true},"balance_after":59618,"source":{"system":"sec-edgar","filing":"0001213900-25-122379","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025122379/ownership.xml","form_type":"4"}},{"id":970547,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":37979,"kind":"person","name":"DOW GEOFFREY S","position":1,"cik":"0001977231","reported_name":"DOW GEOFFREY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-12-12T13:39:45.000Z","date":"2025-12-11","kind":"purchase","planned":false,"acquired":true,"shares":3613,"price":0.9184,"value":3318.1792,"ownership":{"direct":true},"balance_after":49948,"source":{"system":"sec-edgar","filing":"0001213900-25-120948","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025120948/ownership.xml","form_type":"4"}},{"id":970546,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":37979,"kind":"person","name":"DOW GEOFFREY S","position":1,"cik":"0001977231","reported_name":"DOW GEOFFREY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-12-12T13:39:45.000Z","date":"2025-12-10","kind":"purchase","planned":false,"acquired":true,"shares":9350,"price":0.9504,"value":8886.24,"ownership":{"direct":true},"balance_after":46335,"source":{"system":"sec-edgar","filing":"0001213900-25-120948","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025120948/ownership.xml","form_type":"4"}},{"id":1040083,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":37979,"kind":"person","name":"DOW GEOFFREY S","position":1,"cik":"0001977231","reported_name":"DOW GEOFFREY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-09-15T20:38:01.000Z","date":"2025-09-12","kind":"grant","planned":false,"acquired":true,"shares":7201,"price":1.3881,"value":9995.7081,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reported transaction reflects an open-market purchase by the reporting person on September 12, 2025."}],"balance_after":33372,"source":{"system":"sec-edgar","filing":"0001213900-25-087681","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025087681/ownership.xml","form_type":"4"}},{"id":1117190,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":37979,"kind":"person","name":"DOW GEOFFREY S","position":1,"cik":"0001977231","reported_name":"DOW GEOFFREY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-06-09T21:23:56.000Z","date":"2025-06-09","kind":"grant","planned":false,"acquired":true,"shares":4376,"price":2.9855,"value":13064.548,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects a 1-for-5 reverse stock split effective February 24, 2025. As a result, the reporting person's direct beneficial ownership was adjusted from 108,974 shares to 21,795 shares, and indirect beneficial ownership was adjusted from 55,596 shares to 11,119 shares. Fractional shares resulting from the split were rounded up to the nearest whole share."}],"balance_after":26171,"source":{"system":"sec-edgar","filing":"0001213900-25-052709","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025052709/ownership.xml","form_type":"4"}},{"id":1295271,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":37979,"kind":"person","name":"DOW GEOFFREY S","position":1,"cik":"0001977231","reported_name":"DOW GEOFFREY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-24T21:52:30.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":525000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options were fully vested as of January 2, 2025, the grant date."}],"balance_after":525000,"derivative":{"exercise_price":1.31,"exercise_date":"2025-01-02","expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":525000},"source":{"system":"sec-edgar","filing":"0001213900-25-006572","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025006572/ownership.xml","form_type":"4"}},{"id":1298470,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":37979,"kind":"person","name":"DOW GEOFFREY S","position":1,"cik":"0001977231","reported_name":"DOW GEOFFREY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-01-21T22:00:27.000Z","date":"2025-01-17","kind":"grant","planned":false,"acquired":true,"shares":14394,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":108974,"source":{"system":"sec-edgar","filing":"0001213900-25-005055","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025005055/ownership.xml","form_type":"4"}},{"id":1338449,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":37979,"kind":"person","name":"DOW GEOFFREY S","position":1,"cik":"0001977231","reported_name":"DOW GEOFFREY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-12-09T22:07:49.000Z","date":"2024-12-09","kind":"purchase","planned":false,"acquired":true,"shares":35823,"price":1.2719,"value":45563.2737,"ownership":{"direct":true},"balance_after":94580,"source":{"system":"sec-edgar","filing":"0001213900-24-107011","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024107011/ownership.xml","form_type":"4"}},{"id":1338448,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":37979,"kind":"person","name":"DOW GEOFFREY S","position":1,"cik":"0001977231","reported_name":"DOW GEOFFREY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-12-09T22:07:49.000Z","date":"2024-12-06","kind":"purchase","planned":false,"acquired":true,"shares":20579,"price":1.1989,"value":24672.1631,"ownership":{"direct":true},"balance_after":58757,"source":{"system":"sec-edgar","filing":"0001213900-24-107011","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024107011/ownership.xml","form_type":"4"}},{"id":1338447,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":37979,"kind":"person","name":"DOW GEOFFREY S","position":1,"cik":"0001977231","reported_name":"DOW GEOFFREY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-12-09T22:07:49.000Z","date":"2024-12-05","kind":"purchase","planned":false,"acquired":true,"shares":17549,"price":1.1123,"value":19519.7527,"ownership":{"direct":true},"balance_after":38178,"source":{"system":"sec-edgar","filing":"0001213900-24-107011","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024107011/ownership.xml","form_type":"4"}},{"id":1355458,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":37979,"kind":"person","name":"DOW GEOFFREY S","position":1,"cik":"0001977231","reported_name":"DOW GEOFFREY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-11-21T23:14:45.000Z","date":"2024-11-21","kind":"purchase","planned":false,"acquired":true,"shares":3500,"price":0.9129,"value":3195.15,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Adjusted for the Issuer's 12-for-1 reverse stock split effected on August 12, 2024."}],"balance_after":20629,"source":{"system":"sec-edgar","filing":"0001213900-24-101110","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024101110/ownership.xml","form_type":"4"}},{"id":1355457,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":37979,"kind":"person","name":"DOW GEOFFREY S","position":1,"cik":"0001977231","reported_name":"DOW GEOFFREY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-11-21T23:14:45.000Z","date":"2024-11-20","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":0.9243,"value":924.3,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Adjusted for the Issuer's 12-for-1 reverse stock split effected on August 12, 2024."}],"balance_after":17129,"source":{"system":"sec-edgar","filing":"0001213900-24-101110","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024101110/ownership.xml","form_type":"4"}},{"id":1355456,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":37979,"kind":"person","name":"DOW GEOFFREY S","position":1,"cik":"0001977231","reported_name":"DOW GEOFFREY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-11-21T23:14:45.000Z","date":"2024-11-19","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":0.8992,"value":2248.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Adjusted for the Issuer's 12-for-1 reverse stock split effected on August 12, 2024."}],"balance_after":16129,"source":{"system":"sec-edgar","filing":"0001213900-24-101110","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024101110/ownership.xml","form_type":"4"}},{"id":1506538,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":37979,"kind":"person","name":"DOW GEOFFREY S","position":1,"cik":"0001977231","reported_name":"DOW GEOFFREY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2024-05-22T00:19:36.000Z","date":"2024-05-16","kind":"exercise","planned":false,"acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Geoffrey Dow was granted a total of 85,000 restricted stock units on November 21, 2023 that were fully vested as of the grant date. Each RSU represents the right to receive, at settlement, one share of common stock."},{"field":"security","element":"securityTitle","label":"F5","text":"17,000 shares underlying the RSUs were settled as of May 16, 2024. After the settlement of the shares of common stock that were underlying the 17,000 RSUs, Geoffrey Dow did not own any RSUs."},{"field":"shares","element":"transactionShares","label":"F5","text":"17,000 shares underlying the RSUs were settled as of May 16, 2024. After the settlement of the shares of common stock that were underlying the 17,000 RSUs, Geoffrey Dow did not own any RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"17,000 shares underlying the RSUs were settled as of May 16, 2024. After the settlement of the shares of common stock that were underlying the 17,000 RSUs, Geoffrey Dow did not own any RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"17,000 shares underlying the RSUs were settled as of May 16, 2024. After the settlement of the shares of common stock that were underlying the 17,000 RSUs, Geoffrey Dow did not own any RSUs."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"17,000 shares underlying the RSUs were settled as of May 16, 2024. After the settlement of the shares of common stock that were underlying the 17,000 RSUs, Geoffrey Dow did not own any RSUs."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001213900-24-045705","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024045705/ownership.xml","form_type":"4"}},{"id":1506537,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":37979,"kind":"person","name":"DOW GEOFFREY S","position":1,"cik":"0001977231","reported_name":"DOW GEOFFREY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2024-05-22T00:19:36.000Z","date":"2024-04-12","kind":"exercise","planned":false,"acquired":false,"shares":68000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Geoffrey Dow was granted a total of 85,000 restricted stock units on November 21, 2023 that were fully vested as of the grant date. Each RSU represents the right to receive, at settlement, one share of common stock."},{"field":"security","element":"securityTitle","label":"F4","text":"68,000 shares underlying the RSUs were settled on April 12, 2024. After the settlement of the shares of common stock that were underlying the 68,000 RSUs, Geoffrey Dow owned a total of 17,000 RSUs."},{"field":"shares","element":"transactionShares","label":"F4","text":"68,000 shares underlying the RSUs were settled on April 12, 2024. After the settlement of the shares of common stock that were underlying the 68,000 RSUs, Geoffrey Dow owned a total of 17,000 RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"68,000 shares underlying the RSUs were settled on April 12, 2024. After the settlement of the shares of common stock that were underlying the 68,000 RSUs, Geoffrey Dow owned a total of 17,000 RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"68,000 shares underlying the RSUs were settled on April 12, 2024. After the settlement of the shares of common stock that were underlying the 68,000 RSUs, Geoffrey Dow owned a total of 17,000 RSUs."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"68,000 shares underlying the RSUs were settled on April 12, 2024. After the settlement of the shares of common stock that were underlying the 68,000 RSUs, Geoffrey Dow owned a total of 17,000 RSUs."}],"balance_after":17000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":68000},"source":{"system":"sec-edgar","filing":"0001213900-24-045705","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024045705/ownership.xml","form_type":"4"}},{"id":1506536,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":37979,"kind":"person","name":"DOW GEOFFREY S","position":1,"cik":"0001977231","reported_name":"DOW GEOFFREY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2024-05-22T00:19:36.000Z","date":"2023-11-21","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Geoffrey Dow was granted a total of 85,000 restricted stock units on November 21, 2023 that were fully vested as of the grant date. Each RSU represents the right to receive, at settlement, one share of common stock."},{"field":"shares","element":"transactionShares","label":"F3","text":"Geoffrey Dow was granted a total of 85,000 restricted stock units on November 21, 2023 that were fully vested as of the grant date. Each RSU represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Geoffrey Dow was granted a total of 85,000 restricted stock units on November 21, 2023 that were fully vested as of the grant date. Each RSU represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Geoffrey Dow was granted a total of 85,000 restricted stock units on November 21, 2023 that were fully vested as of the grant date. Each RSU represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Geoffrey Dow was granted a total of 85,000 restricted stock units on November 21, 2023 that were fully vested as of the grant date. Each RSU represents the right to receive, at settlement, one share of common stock."}],"balance_after":85000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001213900-24-045705","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024045705/ownership.xml","form_type":"4"}},{"id":1506535,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":37979,"kind":"person","name":"DOW GEOFFREY S","position":1,"cik":"0001977231","reported_name":"DOW GEOFFREY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-05-22T00:19:36.000Z","date":"2024-05-16","kind":"exercise","planned":false,"acquired":true,"shares":17000,"price":0.223,"value":3791.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"17,000 shares underlying the RSUs were settled on May 16, 2024 (the \"5/24 Shares\"). Geoffrey Dow owned 78,482 shares of common stock and through the Dow Trust owned 667,143 shares of common stock immediately prior to the issuance of the 5/24 Shares. As of May 16, 2024, Geoffrey Dow owned a total of 762,625 shares of common stock, consisting of (i) 95,482 shares of common stock held in the name of Geoffrey Dow and (ii) 667,143 shares of common stock held by the Dow Trust."},{"field":"shares","element":"transactionShares","label":"F1","text":"Geoffrey Dow was granted a total of 85,000 restricted stock units (\"RSUs\") on November 21, 2023 that were fully vested as of the grant date. 68,000 shares underlying the RSUs were settled on April 12, 2024 (the \"4/24 Shares\"). Geoffrey Dow owned 10,482 shares of common stock and through the Geoffrey S. Dow Revocable Trust (the \"Dow Trust\"), as trustee and having control over the voting and disposition of the shares of common stock held by the Dow Trust, owned 667,143 shares of common stock immediately prior to the issuance of the 4/24 Shares. As of April 12, 2024, Geoffrey Dow owned a total of 745,625 shares of common stock, consisting of (i) 78,482 shares of common stock held in the name of Geoffrey Dow and (ii) 667,143 shares of common stock held by the Dow Trust."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"17,000 shares underlying the RSUs were settled on May 16, 2024 (the \"5/24 Shares\"). Geoffrey Dow owned 78,482 shares of common stock and through the Dow Trust owned 667,143 shares of common stock immediately prior to the issuance of the 5/24 Shares. As of May 16, 2024, Geoffrey Dow owned a total of 762,625 shares of common stock, consisting of (i) 95,482 shares of common stock held in the name of Geoffrey Dow and (ii) 667,143 shares of common stock held by the Dow Trust."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"17,000 shares underlying the RSUs were settled on May 16, 2024 (the \"5/24 Shares\"). Geoffrey Dow owned 78,482 shares of common stock and through the Dow Trust owned 667,143 shares of common stock immediately prior to the issuance of the 5/24 Shares. As of May 16, 2024, Geoffrey Dow owned a total of 762,625 shares of common stock, consisting of (i) 95,482 shares of common stock held in the name of Geoffrey Dow and (ii) 667,143 shares of common stock held by the Dow Trust."}],"balance_after":762625,"source":{"system":"sec-edgar","filing":"0001213900-24-045705","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024045705/ownership.xml","form_type":"4"}},{"id":1506534,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":37979,"kind":"person","name":"DOW GEOFFREY S","position":1,"cik":"0001977231","reported_name":"DOW GEOFFREY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-05-22T00:19:36.000Z","date":"2024-04-12","kind":"exercise","planned":false,"acquired":true,"shares":68000,"price":0.2668,"value":18142.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Geoffrey Dow was granted a total of 85,000 restricted stock units (\"RSUs\") on November 21, 2023 that were fully vested as of the grant date. 68,000 shares underlying the RSUs were settled on April 12, 2024 (the \"4/24 Shares\"). Geoffrey Dow owned 10,482 shares of common stock and through the Geoffrey S. Dow Revocable Trust (the \"Dow Trust\"), as trustee and having control over the voting and disposition of the shares of common stock held by the Dow Trust, owned 667,143 shares of common stock immediately prior to the issuance of the 4/24 Shares. As of April 12, 2024, Geoffrey Dow owned a total of 745,625 shares of common stock, consisting of (i) 78,482 shares of common stock held in the name of Geoffrey Dow and (ii) 667,143 shares of common stock held by the Dow Trust."},{"field":"shares","element":"transactionShares","label":"F1","text":"Geoffrey Dow was granted a total of 85,000 restricted stock units (\"RSUs\") on November 21, 2023 that were fully vested as of the grant date. 68,000 shares underlying the RSUs were settled on April 12, 2024 (the \"4/24 Shares\"). Geoffrey Dow owned 10,482 shares of common stock and through the Geoffrey S. Dow Revocable Trust (the \"Dow Trust\"), as trustee and having control over the voting and disposition of the shares of common stock held by the Dow Trust, owned 667,143 shares of common stock immediately prior to the issuance of the 4/24 Shares. As of April 12, 2024, Geoffrey Dow owned a total of 745,625 shares of common stock, consisting of (i) 78,482 shares of common stock held in the name of Geoffrey Dow and (ii) 667,143 shares of common stock held by the Dow Trust."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Geoffrey Dow was granted a total of 85,000 restricted stock units (\"RSUs\") on November 21, 2023 that were fully vested as of the grant date. 68,000 shares underlying the RSUs were settled on April 12, 2024 (the \"4/24 Shares\"). Geoffrey Dow owned 10,482 shares of common stock and through the Geoffrey S. Dow Revocable Trust (the \"Dow Trust\"), as trustee and having control over the voting and disposition of the shares of common stock held by the Dow Trust, owned 667,143 shares of common stock immediately prior to the issuance of the 4/24 Shares. As of April 12, 2024, Geoffrey Dow owned a total of 745,625 shares of common stock, consisting of (i) 78,482 shares of common stock held in the name of Geoffrey Dow and (ii) 667,143 shares of common stock held by the Dow Trust."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Geoffrey Dow was granted a total of 85,000 restricted stock units (\"RSUs\") on November 21, 2023 that were fully vested as of the grant date. 68,000 shares underlying the RSUs were settled on April 12, 2024 (the \"4/24 Shares\"). Geoffrey Dow owned 10,482 shares of common stock and through the Geoffrey S. Dow Revocable Trust (the \"Dow Trust\"), as trustee and having control over the voting and disposition of the shares of common stock held by the Dow Trust, owned 667,143 shares of common stock immediately prior to the issuance of the 4/24 Shares. As of April 12, 2024, Geoffrey Dow owned a total of 745,625 shares of common stock, consisting of (i) 78,482 shares of common stock held in the name of Geoffrey Dow and (ii) 667,143 shares of common stock held by the Dow Trust."}],"balance_after":745625,"source":{"system":"sec-edgar","filing":"0001213900-24-045705","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024045705/ownership.xml","form_type":"4"}},{"id":1660506,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":37979,"kind":"person","name":"DOW GEOFFREY S","position":1,"cik":"0001977231","reported_name":"DOW GEOFFREY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Warrant","published_at":"2024-02-02T20:33:59.000Z","date":"2024-01-31","kind":"purchase","planned":false,"acquired":true,"shares":25974,"price":0.01,"value":259.74,"ownership":{"direct":true},"balance_after":25974,"derivative":{"exercise_price":0.4235,"exercise_date":"2024-01-31","expiration_date":"2029-01-31","underlying":"Common Stock","underlying_shares":25974},"source":{"system":"sec-edgar","filing":"0001213900-24-009603","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024009603/ownership.xml","form_type":"4"}},{"id":1660505,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":37979,"kind":"person","name":"DOW GEOFFREY S","position":1,"cik":"0001977231","reported_name":"DOW GEOFFREY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-02T20:33:59.000Z","date":"2024-01-31","kind":"purchase","planned":false,"acquired":true,"shares":25974,"price":0.375,"value":9740.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 667,143 shares of common stock held by the Geoffrey S. Dow Revocable Trust, of which Geoffrey Dow is the trustee and has voting and dispositive control."}],"balance_after":703599,"source":{"system":"sec-edgar","filing":"0001213900-24-009603","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024009603/ownership.xml","form_type":"4"}},{"id":1830711,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":37979,"kind":"person","name":"DOW GEOFFREY S","position":1,"cik":"0001977231","reported_name":"DOW GEOFFREY S","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-07-12T18:51:47.000Z","date":"2023-07-12","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Non-Qualified Stock Option granted pursuant that certain Employment Agreement, dated January 1, 2023, between the Issuer and the Reporting Person, subject to terms and conditions of the Issuer's 2022 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Vests in 15,000 increments on the last day of each fiscal quarter (March 31st, June 30th, September 30th, December 31st)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Date indicated is the date of grant."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Vests in 15,000 increments on the last day of each fiscal quarter (March 31st, June 30th, September 30th, December 31st)."}],"balance_after":300000,"derivative":{"exercise_price":5.3,"exercise_date":"2023-07-12","expiration_date":"2028-07-12","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001575872-23-001134","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000157587223001134/ownership.xml","form_type":"4"}}]}